Tagging antibiotic-resistant bacteria with a chimeric agent to activate the immune system

by

Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

Fluorescent chimeric C3b tag binds E. coli S. EVOS microscope images of bound chimeric C3b tag to P4-NR smooth E. coli bacteria. Bacteria were grown to O.D. = 1 and incubated together with the fluorescent chimeric tag for 30 min at 37 °C in PBS. (A) Control sample which contained P4-NR smooth E. coli bacteria dyed with Syto9. (B) Binding to 0.22 mg/mL fluorescent chimeric tag. (C) Binding to 0.022 mg/mL fluorescent chimeric tag. Images shown were taken at a magnification of 40×. Credit: Bioconjugate Chemistry (2024). DOI: 10.1021/acs.bioconjchem.4c00291

Researchers at the Hebrew University of Jerusalem have developed an innovative approach to fight antibiotic-resistant bacteria by creating a "tagging" technique that helps the immune system recognize and eliminate these elusive pathogens.

The study, led by Prof. Zvi Hayouka, Ph.D. student Yael Belo, and Dr. Einav Malach from the Institute of Biochemistry, Food Science, and Nutrition at the Robert H. Smith Faculty of Agriculture, Food & Environment, showcases a novel therapeutic strategy to combat infections that evade immune system detection. The research paper titled "Recruiting the Immune System against Pathogenic Bacteria Using High-Affinity Chimeric Tags" is published in the journal Bioconjugate Chemistry.

Pathogens often escape immune system defenses by altering their structures or producing enzymes that interfere with immune responses, leading to severe infections. Addressing this challenge, the researchers developed a chimeric agent—essentially a fusion of two different molecules—that combines a peptide bacterial binder with an immune-protein tag, which the immune system recognizes. This tagging agent effectively flags the pathogen, signaling the immune system to destroy it.

This innovation centers on a bacterial peptide binder conjugated to C3b, a protein that activates the immune system's complement pathway. The researchers demonstrated that this chimeric tag could effectively bind to complement-resistant E. coli, achieving a 90% reduction in bacterial cells after recruiting other compliment proteins.

This tagging approach not only targets bacteria but also shows promise for tagging other microbial threats, like fungi, suggesting a versatile pathway to recruit the immune system against a range of pathogens. By enhancing complement sensitivity in previously resistant pathogens, this strategy paves the way for new, selective antimicrobial agents that may one day transform the way we combat bacterial infections.

This research marks an important step forward in developing effective treatments against pathogens that can evade the immune system, opening new doors for innovative therapies in the ongoing fight against drug-resistant infections.

More information: Yael Belo et al, Recruiting the Immune System against Pathogenic Bacteria Using High-Affinity Chimeric Tags, Bioconjugate Chemistry (2024). DOI: 10.1021/acs.bioconjchem.4c00291

Journal information: Bioconjugate Chemistry

Provided by Hebrew University of Jerusalem